Skip to main content

Risikostratifizierung im 1. Trimester

  • Chapter
  • First Online:
Die Geburtshilfe

Part of the book series: Springer Reference Medizin ((SRM))

  • 13k Accesses

Zusammenfassung

Das Ersttrimesterscreening (ETS) zwischen 11 und 13 SSW – zunächst als Screeninguntersuchung auf Chromosomenstörungen konzipiert – umfasst heute weitere Screeninguntersuchungen auf typische Schwangerschaftskomplikationen. Damit wurde die klassische Schwangerenvorsorge revolutioniert, da mit der Etablierung des erweiterten ETS zahlreiche wichtige Fragen bereits in der Frühschwangerschaft beantwortet werden können und eine risikoadaptierte Schwangerenvorsorge möglich wurde.

Im Sinne einer primären Prävention kann so bereits vor klinischer Manifestation einer Schwangerschaftserkrankung das Risikokollektiv auf der Basis von anamnestischen Einflussfaktoren in Kombination mit biochemischen und biophysikalischen Parametern definiert werden, um effektive Maßnahmen zur Verhinderung der entsprechenden Komplikation treffen zu können. Wünschenswerte Konsequenz ist eine deutliche Absenkung der Prävalenz typischer Schwangerschaftskomplikationen, insbesondere der Präeklampsie und der Frühgeburt.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  • Akolekar R, Syngelaki A, Sarquis R, Zvanca M, Nicolaides KH (2011) Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11–13 Weeks. Prenat Diagn 31(1):66–74

    Article  PubMed  Google Scholar 

  • Akolekar R, Syngelaki A, Poon L, Wright D, Nicolaides KH (2013) Competing risks model in early screening for preeclampsia by biophysical and biochemical markers. Fetal Diagn Ther 33(1):8–15

    Article  PubMed  Google Scholar 

  • Anderson UD, Olsson MG, Kristensen KH, Åkerström B, Hansson SR (2012) Review: biochemical markers to predict preeclampsia. Placenta 33:42–47

    Article  Google Scholar 

  • Bujold E, Roberge S, Lacasse Y, Bureau M, Audibert F, Marcoux S et al (2010) Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol 116(2 Pt 1):402–414

    Article  PubMed  Google Scholar 

  • Greco E, Lange A, Ushakov F, Calvo JR, Nicolaides KH (2010) Prediction of spontaneous preterm delivery from endocervical length at 11 to 13 weeks. Prenat Diagn 31(1):84–89

    Article  Google Scholar 

  • Greco E, Gupta R, Syngelaki A, Poon LCY, Nicolaides KH (2012) First-trimester screening for spontaneous preterm delivery with maternal characteristics and cervical length. Fetal Diagn Ther 31(3):154–161

    Article  PubMed  Google Scholar 

  • Kagan KO, Hoopmann M, Abele H, Wallwiener D (2012) Future developments in obstetrics. Gynakologe 45(9):684–689

    Article  Google Scholar 

  • Khalil A, Nicolaides KH (2013) How to record uterine artery doppler in the first trimester. Ultrasound Obstet Gynecol 42:478

    CAS  PubMed  Google Scholar 

  • Khalil A, Sodre D, Syngelaki A, Akolekar R, Nicolaides KH (2012) Maternal hemodynamics at 11–13 weeks of gestation in pregnancies delivering small for gestational age neonates. Fetal Diagn Ther 32(4):231–238

    Article  CAS  PubMed  Google Scholar 

  • Kim YJ (2013) Pathogenesis and promising non-invasive markers for preeclampsia. Obstet Gynecol Sci Ultrasound 56(1):2

    Article  Google Scholar 

  • Meads CA, Cnossen JS, Meher S, Juarez-Garcia A, ter Riet G, Duley L et al (2008) Methods of prediction and prevention of pre-eclampsia: systematic reviews of accuracy and effectiveness literature with economic modelling. Health Technol Assess(Winchester, Engl) 12(6):iii–iv, 1–270

    CAS  Google Scholar 

  • Myers JE, Kenny LC, McCowan L, Chan E, Dekker GA, Poston L et al (2013) Angiogenic factors combined with clinical risk factors to predict preterm pre-eclampsia in nulliparous women: a predictive test accuracy study. BJOG 120(10):1215–1223

    Article  CAS  PubMed  Google Scholar 

  • Nicolaides KH (2011) A model for a new pyramid of prenatal care based on the 11 to 13 weeks’ assessment. Prenat Diagn 31(1):3–6

    Article  PubMed  Google Scholar 

  • Onwudiwe N, Yu CKH, Poon LCY, Spiliopoulos I, Nicolaides KH (2008) Prediction of pre-eclampsia by a combination of maternal history, uterine artery doppler and mean arterial pressure. Ultrasound Obstet Gynecol 32(7):877–883

    Article  CAS  PubMed  Google Scholar 

  • Papageorghiou AT, Yu CK, Bindra R, Pandis G, Nicolaides KHF, Medicine Foundation Second Trimester Screening Group et al (2001) Multicenter screening for pre-eclampsia and fetal growth restriction by transvaginal uterine artery doppler at 23 weeks of gestation. Ultrasound Obstet Gynecol 18(5):441–449

    Article  CAS  PubMed  Google Scholar 

  • Papantoniou N, Bagiokos V, Agiannitopoulos K, Kolialexi A, Destouni A, Tounta G et al (2013) RASSF1A in maternal plasma as a molecular marker of preeclampsia. Prenat Diagn 33(7):682–687

    Article  CAS  PubMed  Google Scholar 

  • Papastefanou I, Souka AP, Pilalis A, Eleftheriades M, Michalitsi V, Kassanos D (2011) First trimester prediction of small- and large-for-gestation neonates by an integrated model incorporating ultrasound parameters, biochemical indices and maternal characteristics. Acta Obstet Gynecol Scand 91(1):104–111

    Article  PubMed  Google Scholar 

  • Plasencia W, Akolekar R, Dagklis T, Veduta A, Nicolaides KH (2011) Placental volume at 11–13 Weeks’ gestation in the prediction of birth weight percentile. Fetal Diagn Ther 30(1):23–28

    Article  PubMed  Google Scholar 

  • Plasencia W, González Dávila E, Tetilla V, Padrón Pérez E, García Hernández JA, González González NL (2012) First-trimester screening for large-for-gestational-age infants. Ultrasound Obstet Gynecol 39(4):389–395

    Article  CAS  PubMed  Google Scholar 

  • Poon LCY, Musci T, Song K, Syngelaki A, Nicolaides KH (2013a) Maternal plasma cell-free fetal and maternal DNA at 11-13 weeks' gestation: relation to fetal and maternal characteristics and pregnancy outcomes. Fetal Diagn Ther 33(4):215–223

    Article  CAS  PubMed  Google Scholar 

  • Poon LCY, Syngelaki A, Akolekar R, Lai J, Nicolaides KH (2013b) Combined screening for preeclampsia and small for gestational age at 11–13 weeks. Fetal Diagn Ther 33(1):16–27

    Article  PubMed  Google Scholar 

  • Retzke JD, Sonek JD, Lehmann J, Yazdi B, Kagan KO (2013) Comparison of three methods of cervical measurement in the first trimester: single-line, two-line, and tracing. Prenat Diagn 33(3):262–268

    Article  CAS  PubMed  Google Scholar 

  • Roberge S, Nicolaides KH, Demers S, Villa P, Bujold E (2013) Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: a meta-analysis. Ultrasound Obstet Gynecol Ultrasound 41(5):491–499

    Article  CAS  Google Scholar 

  • Roberts JM, Myatt L, Spong CY, Thom EA, Hauth JC, Leveno KJ et al (2010) Vitamins C and E to prevent complications of pregnancy-associated hypertension. NEJM 362(14):1282–1291

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Rumbold AR, Crowther CA, Haslam RR, Dekker GA, Robinson JS, ACTS Study Group (2006) Vitamins C and E and the risks of preeclampsia and perinatal complications. NEJM 354(17):1796–1806

    Article  CAS  PubMed  Google Scholar 

  • Velauthar L, Plana MN, Kalidindi M, Zamora J, Thilaganathan B, Illanes SE et al (2013) Uterine artery doppler in the first trimester as a risk factor for adverse pregnancy outcomes: a meta-analysis involving 55,974 women. Ultrasound Obstet Gynecol 43:500

    Article  Google Scholar 

  • Villa PM, Hämäläinen E, Mäki A, Räikkönen K, Pesonen A-K, Taipale P et al (2013) Vasoactive agents for the prediction of early- and late-onset preeclampsia in a high-risk cohort. BMC Pregnancy Childbirth 13:110

    Article  PubMed  PubMed Central  Google Scholar 

  • Wright D, Akolekar R, Syngelaki A, Poon LCY, Nicolaides KH (2012) A competing risks model in early screening for preeclampsia. Fetal Diagn Ther 32(3):171–178

    Article  PubMed  Google Scholar 

  • Xiong X, Demianczuk NN, Saunders LD, Wang F-L, Fraser WD (2002) Impact of preeclampsia and gestational hypertension on birth weight by gestational age. Am J Epidemiol 155(3):203–209

    Article  PubMed  Google Scholar 

  • Yu CKH, Papageorghiou AT, Parra M, Palma Dias R, Nicolaides KHF, Medicine Foundation Second Trimester Screening Group et al (2003) Randomized controlled trial using Low-dose aspirin in the prevention of pre-eclampsia in women with abnormal uterine artery doppler at 23 weeks' gestation. Ultrasound Obstet Gynecol 22(3):233–239

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Karl Oliver Kagan .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Kagan, K.O., Kürzl, R. (2016). Risikostratifizierung im 1. Trimester. In: Schneider, H., Husslein, P., Schneider, KT. (eds) Die Geburtshilfe. Springer Reference Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-45064-2_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-45064-2_11

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-45063-5

  • Online ISBN: 978-3-662-45064-2

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics